Cambridge biotech Sage to open postpartum depression support center in North Carolina

A year after announcing a partnership with the University of North Carolina School of Medicine to develop postpartum depression treatments, Cambridge-based Sage Therapeutics is preparing to open a patient support center in Raleigh with an AmerisourceBergen subsidiary. The goal is to address postpartum depression through a new, end-to-end patient support model, Sage (Nasdaq: SAGE) Chief Business Officer Michael Cloonan said on an earnings call last week. The company is awaiting possible FDA approval…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news